Autologous Cellular Graft in Surgical Treatment of Vitiligo
Reason given: lack of availability of the needed kits
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- Cairo University
- Trial code
- NCT05503368
- Record updated
- 25 January 2023
- Original description
This is a double blinded self controlled randomized trial to assess Autologous Micro Cellular Grafts in surgical treatment of stable resistant vitiligo. Given the stem cells, progenitor cells, and growth factors rich hair follicle based suspension resulting from Autologous Cellular Micro grafts (ACM), we aim at assessing the efficacy of ACM generated suspension in comparison to follicle cell suspension in surgical treatment of stable resistant vitiligo.Read full original descriptionShow less
Autologous Cellular Micro-graft in Surgical Treatment of Stable Resistant Vitiligo: A Randomized Self-controlled Trial
This is a double blinded self controlled randomized trial to assess Autologous Micro Cellular Grafts in surgical treatment of stable resistant vitiligo. Given the stem cells, progenitor cells, and growth factors rich hair follicle based suspension resulting from Autologous Cellular Micro grafts (ACM), we aim at assessing the efficacy of ACM generated suspension in comparison to follicle cell suspension in surgical treatment of stable resistant vitiligo.
Inclusion: Patients with non-segmental vitiligo (NSV) / segmental resistant lesions; with either 2 comparable lesions or large patches that can be divided; Stability for ≥ 1 year; Age >18 years; Lack of treatment for at least 1 month prior to surgery.
Exclusion: Bleeding tendency; Age < 18 years; -Vitiligo lesions responsive to conventional treatment modalities; Active vitiligo; new lesions, expansion of old lesions or koebnerization in < 1 year; Keloidal tendency; Pregnant females.